TLR5 and breast carcinoma: Similarly, in breast cancer, TLR5 activation in vitro inhibited tumor cell proliferation and colony formation by decreasing cyclin B1, cyclin D1 and cyclin E2 expression and increasing CDK inhibitor p27.